Julianne Bruno

Insider Reports History

Location
Boston, MA
Signature
/s/ Lori Firmani, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Julianne Bruno:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Operating Officer Common Shares 10,544 $434,729 $41.23 21 Mar 2025 Direct
CRISPR Therapeutics AG Chief Operating Officer Common Shares 7,088 $292,238 $41.23 20 Mar 2025 The Julianne Bruno 2022 GRAT
Galecto, Inc. Director Common Stock 8,032 $59,999 $7.47 10 Nov 2025 Direct
CRISPR Therapeutics AG Chief Operating Officer Stock Option (Right to Buy) 36,666 14 Mar 2025 Direct
CRISPR Therapeutics AG Chief Operating Officer Restricted Stock Units 11,250 20 Mar 2025 Direct

Insider Reports Filed by Julianne Bruno

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLTO Galecto, Inc. 10 Nov 2025 0 $0 3 Director 17 Nov 2025, 21:44
CRSP CRISPR Therapeutics AG 20 Mar 2025 3 -$70,668 4 Chief Operating Officer 24 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 14 Mar 2025 2 $0 4 Chief Operating Officer 18 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 10 Mar 2025 6 -$59,050 4 Chief Operating Officer 12 Mar 2025, 19:05
CRSP CRISPR Therapeutics AG 18 Feb 2025 3 -$17,582 4 Chief Operating Officer 19 Feb 2025, 17:35
CRSP CRISPR Therapeutics AG 16 Oct 2024 1 $0 4 Chief Operating Officer 18 Oct 2024, 17:35
CRSP CRISPR Therapeutics AG 20 Jun 2024 3 -$188,799 4 Chief Operating Officer 24 Jun 2024, 17:35
CRSP CRISPR Therapeutics AG 23 May 2024 1 $0 4 Chief Operating Officer 24 May 2024, 16:15
CRSP CRISPR Therapeutics AG 23 May 2024 0 $0 3 Chief Operating Officer 23 May 2024, 16:25